Iovance Biotherapeutics, Inc. (IOVA): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001193125-26-450084

Filer

Iovance Biotherapeutics, Inc. (CIK 1425205)